Xcout IntelOragenics Inc. competitors & alternatives
The 12 closest competitors and alternatives to Oragenics Inc. among biotechnology companies — ranked by similarity to what Oragenics Inc. actually does, not by market-cap band.
Subscribe to see Oragenics Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Oragenics Inc.
Oragenics, Inc. is a biotechnology development-stage company incorporated in Florida in 1996 and headquartered in Lakewood Ranch, Florida. It is dedicated to fighting infectious diseases, including coronaviruses and multidrug-resistant pathogens.
Oragenics Inc. at a glance
Oragenics Inc. is a biotechnology company headquartered in Lakewood Ranch, United States. It is publicly listed (OGEN) with a market capitalisation of $2.3M. Xcout tracks 14 named people at Oragenics Inc., including Janet Huffman (CEO, President, Secretary & Treasurer).
Oragenics Inc. leadership
- Janet HuffmanCEO, President, Secretary & Treasurer
- John SpencerChief Financial Officer
- James KellyChief Medical Officer
- William Franklin Peacock FACCChief Clinical Officer
- Charles L. PopeExecutive Chairman
- Alan JoslynDirector
8 more named people on record for Oragenics Inc., with roles, board committees and tenure — see the full roster →
Top 12 Oragenics Inc. competitors
Ranked by semantic similarity — how close each company is to Oragenics Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
This biopharmaceutical company is dedicated to developing innovative antimicrobial therapies. Its array of anti-infective products is designed to tackle specific viral conditions, including avian influenza, Epstein-Barr Virus (EBV), and hepatitis B and C. Established by Roderic Dale on July 11, 2006, the firm maintains its principal office in Bradenton, Florida.
Biotech
Omnix Medical is a biopharmaceutical company that develops novel antibiotic agents and antimicrobial peptides to treat infections caused by drug-resistant bacteria. The company focuses on creating first-in-its-class anti-infective therapeutics, such as its lead compound OMN6, to target life-threatening bacterial strains.
Similar biotechnology company
Ora Biomedical, Inc. is a longevity biotechnology pharmaceutical company headquartered in Tukwila, Washington, that identifies and develops longevity therapeutics and small molecules.
Biotech
Orgenesis Inc. is a public biotechnology company founded in 2012. It has its primary headquarters located in Germantown, Maryland, United States.
Biotech
Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical company based in Carlsbad, California. The company focuses on the development of novel oral antiviral treatments for viral diseases.
Biotech
Vaxart, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of oral recombinant vaccines administered using temperature-stable tablets that can be stored and shipped without refrigeration, eliminating the need for needle injection. Its development programs for oral vaccine delivery include prophylactic, enteric-coated tablet vaccines for inhibiting norovirus, seasonal influenza, respiratory syncytial virus, and human papillomavirus. It was founded in 2004 by Sean Tucker. Originally incorporated as West Coast Biologicals, Inc. in California in
Similar biotechnology company
C3J Therapeutics, Inc. is a clinical-stage biotechnology company based in Los Angeles, California, focused on improving human health through the development of targeted antimicrobials.
Similar biotechnology company
Biora Therapeutics is a U.S. biotechnology company developing ingestible, device-based platforms for delivering biologic medicines to targeted areas of the gastrointestinal tract and into systemic circulation. Its technologies are intended for use by pharmaceutical and biotechnology companies developing oral or targeted biologic therapies.
Biotech
Matinas BioPharma Holdings, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to identifying and advancing a range of potential therapeutic products. The company's innovative Lipid Nanocrystal (LNC) platform technology underpins its product development efforts. This sophisticated LNC delivery system leverages lipid nano-crystals to transport a diverse array of therapeutic agents, including small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its primary experimental drug, LYPDISO, is a proprietary, prescription-grade omega-3 free fatty acid compound engineered to address cardiovascular and metabolic disorders. Matinas BioPharma is also advancing MAT2203, an orally administered version of amphotericin B. This candidate is currently in Phase II clinical trials, where it is being evaluated for its ability to prevent invasive fungal infections in patients undergoing immunosuppressive treatment. Furthermore, MAT2501, an oral formulation of the broad-spectrum aminoglycoside antibiotic amikacin, has successfully completed Phase I clinical trials. Its aim is to combat a spectrum of multidrug-resistant bacterial infections, such as non-tuberculous mycobacterium, multidrug-resistant gram-negative, and intracellular bacterial pathogens. The company actively engages in collaborations, including a research partnership with the National Institute of Allergy and Infectious Diseases (NIAID) to further the development of Gilead's antiviral drug, remdesivir. Additionally, it has a feasibility collaboration with Genentech, Inc. focused on creating new oral drug formulations. Established in 2013, Matinas BioPharma maintains its corporate headquarters in Bedminster, New Jersey.
Similar biotechnology company
Alopexx, Inc. is a U.S. biotechnology company developing broad-spectrum anti-infective vaccines and antibody-based therapies. Its programs target PNAG, a surface polysaccharide found on many bacterial and fungal pathogens, for potential treatment or prevention of serious infections.
Similar biotechnology company
Forward Therapeutics, Inc. is a biotechnology company headquartered in Palm Beach Gardens, Florida, United States, advancing a data-driven pipeline of oral small molecule therapies for inflammation-driven diseases.
Similar biotechnology company
MycoRx LLC develops new antifungal drug candidates designed to overcome drug resistance and treat fungal infections ranging from recurrent skin conditions to life-threatening sepsis. The company also supports clinical trials for other drug developers and maintains safety standards in the testing and manufacturing of pharmaceutical products.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Oragenics Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Oragenics Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →